Answers are grounded in this paper and cite their sources.
Peroxisome proliferator-activated receptor Gamma (PPAR γ ), a ligand-activated transcription factor, has a role in various cellular functions as well as glucose homeostasis, lipid metabolism, and prevention of oxidative stress. The activators of PPAR γ are already widely used in the treatment of diabetes mellitus. The cardioprotective effect of PPAR γ activation has been studied extensively over the years making them potential therapeutic targets in diseases associated with cardiovascular disorders. However, they are also associated with adverse cardiovascular events such as congestive heart failure and myocardial infarction. This review aims to discuss the role of PPAR γ in the various cardiovascular diseases and summarize the current knowledge on PPAR γ agonists from multiple clinical trials. Finally, we also review the new PPAR γ agonists under development as potential therapeutics with reduced or no adverse effects.
No takes yet. Share an insight, caveat, or question.
Chandra et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: